Home

Granules India Ltd EPS

Image

Granules India Ltd

NSE: GRANULES

EPS

₹ 21.05

Last updated on: Jan 09, 2026

Key Highlights

  • The Earning per Share of Granules India Ltd is ₹ 21.05 as of 09 Jan 26 .
  • The earning per share of Granules India Ltd changed from ₹ 5.56 to ₹ 5.38 over 6 quarters. This represents a CAGR of -2.17% .

Historical Earning per Share of Granules India Ltd

No data available

* All values are in

Company Fundamentals for Granules India Ltd

Market Cap

14,615 Cr

EPS

21.0

P/E Ratio (TTM)

28.6

P/B Ratio (TTM)

3.7

Day’s High

600.9

Day’s Low

576.05

DTE

0.5

ROE

12.9

52 Week High

627.45

52 Week Low

412.05

ROCE

13.4

Market Price of Granules India Ltd

1M

1Y

3Y

5Y

Monitoring Granules India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 Jan 2026602.3
08 Jan 2026607.2
07 Jan 2026612.45
06 Jan 2026611.95
05 Jan 2026605.1
02 Jan 2026615.1
01 Jan 2026619.3
31 Dec 2025598.55
30 Dec 2025598.35
29 Dec 2025603.3

SWOT Analysis Of Granules India Ltd

Strength

4

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Granules India Ltd

Asset Value vs Market Value of Granules India Ltd

Market Value

14,616

Asset Value

Value addition

3.4 X

3,317

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Granules India Ltd14615
Sun Pharmaceutical Industries Ltd415073
Divis Laboratories Ltd175657
Torrent Pharmaceuticals Ltd134121
Cipla Ltd118431
Dr Reddys Laboratories Ltd100944

Historical Market Cap of Granules India Ltd

No data available

* All values are in crore

Historical Revenue of Granules India Ltd

No data available

* All values are in crore

Historical EBITDA of Granules India Ltd

No data available

* All values are in crore

Historical Net Profit of Granules India Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Granules India Ltd News Hub

Granules India Ltd soars 1.63%, up for third straight session

Granules India Ltd rose for a third straight session today. The stock is quoting at Rs 686.45, up 1.

Read more

21 Aug 24

Granules Pharmaceuticals receives USFDA approval for Glycopyrrolate Oral Solution

Granules India announced today that the U.S. Food and Drug Administration (FDA) has approved its Abb

Read more

20 Aug 24

Granules India rises on USFDA nod for oral drug Glycopyrrolate

The ANDA has been filed by Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary o

Read more

20 Aug 24

Granules India receives US FDA nod for depression treatment drug Trazodone

It is bioequivalent and therapeutically equivalent to the reference listed drug Desyrel Tablets of P

Read more

09 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

FAQs for EPS of Granules India Ltd

What is the EPS of Granules India Ltd stock?

The Earnings Per Share (EPS) of Granules India Ltd is 21.05. An EPS is the amount of net income attributed to each share of a common stock.

How is Granules India Ltd EPS calculated?

The EPS of Granules India Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Granules India Ltd report its EPS?

Granules India Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Granules India Ltd EPS?

Factors that influence the EPS of Granules India Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Granules India Ltd EPS growth indicate future performance?

Yes, consistent growth in Granules India Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions